4//SEC Filing
Relypsa Inc 4
Accession 0001140361-16-078629
CIK 0001416792operating
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 12:37 PM ET
Size
27.6 KB
Accession
0001140361-16-078629
Insider Transaction Report
Form 4
Relypsa IncRLYP
Schuetz Thomas J.
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−872→ 0 totalExercise: $4.65Exp: 2021-06-08→ Common Stock (872 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−4,500→ 0 totalExercise: $35.79Exp: 2025-06-03→ Common Stock (4,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−4,500→ 0 totalExercise: $17.00Exp: 2026-06-20→ Common Stock (4,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−1,744→ 0 totalExercise: $4.65Exp: 2021-03-30→ Common Stock (1,744 underlying) - Disposition to Issuer
Common Stock
2016-09-01$32.00/sh−2,250$72,000→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−6,976→ 0 totalExercise: $4.65Exp: 2020-09-28→ Common Stock (6,976 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−10,140→ 0 totalExercise: $7.40Exp: 2023-07-23→ Common Stock (10,140 underlying) - Disposition from Tender
Common Stock
2016-09-01$32.00/sh−33,962$1,086,784→ 2,250 total - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−581→ 0 totalExercise: $4.65Exp: 2020-11-29→ Common Stock (581 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−15,697→ 0 totalExercise: $3.96Exp: 2021-09-13→ Common Stock (15,697 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−9,011→ 0 totalExercise: $3.96Exp: 2022-09-27→ Common Stock (9,011 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2016-09-01−3,828→ 0 totalExercise: $23.96Exp: 2024-06-18→ Common Stock (3,828 underlying)
Footnotes (3)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of July 20, 2016 (the "Merger Agreement"), by and among the Issuer, Galencia AG, a public limited company existing under the laws of Switzerland ("Parent"), and Vifor Pharma USA Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent, on September 1, 2016, shares disposed of in exchange for cash consideration of $32.00 per share, without interest, subject to any applicable withholding taxes.
- [F2]Pursuant to the terms of the Merger Agreement, on September 1, 2016, each award of restricted stock units and stock options was cancelled in exchange for the right to receive $32.00 per share in cash less any applicable withholding taxes and in the case of stock options, less the applicable exercise price.
- [F3]Pursuant to the terms of the Merger Agreement, on September 1, 2016, the stock option was cancelled and no cash payment was made as the exercise price exceeded $32.00 per share.
Documents
Issuer
Relypsa Inc
CIK 0001416792
Entity typeoperating
Related Parties
1- filerCIK 0001416792
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 12:37 PM ET
- Size
- 27.6 KB